At a glance
- Originator Nonindustrial source
- Class Antibacterials
- Mechanism of Action Adenosine triphosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 06 Jul 1998 No-Development-Reported for Tuberculosis in USA (Unknown route)
- 15 May 1995 Preclinical development for Tuberculosis in USA (Unknown route)